Allogene Therapeutics (ALLO) Stock Price
$1.13 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
1 -
Technical
3
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Allogene Therapeutics, AI stock picks, stock alerts and much more.
ALLO AI Stock Analysis
AI stock analysis for ALLO is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Allogene Therapeutics (ALLO) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Allogene Therapeutics (ALLO) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Allogene Therapeutics (ALLO), currently trading at $1.13, will... Sign up to access price prediction.
About ALLO
-
Allogene Therapeutics, Inc.
-
Symbol
ALLO
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
250.7M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$19.97 1.4% |
8 |
 |
Inovio Pharmaceuticals INO |
$2.38 10.2% |
2 |
 |
Moderna MRNA |
$23.51 7.4% |
4 |
 |
Anavex Life Sciences AVXL |
$9.37 2.2% |
5 |
 |
BridgeBio Pharma BBIO |
$51.21 2.6% |
6 |
News
ALLO Alternative Data
Web Traffic
Allogene Therapeutics receives an estimated 40756 monthly visitors to allogene.com, which is down by -16.3% over the last month.
-
Web Traffic
40756
-
Change from Previous Month
16.3%
-
3 Month Change
74.8%
-
YoY Change
74.8%
Twitter Followers
Allogene Therapeutics has 2,620 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.5% over the last month.
-
Twitter Followers
2620
-
Daily Change
0.1%
-
1 Month Change
0.5%
-
3 Month Change
3%
-
YoY Change
3%
LinkedIn Followers
73,778 are following Allogene Therapeutics on LinkedIn, up by 0.8% over the last month.
-
LinkedIn Followers
73778
-
Daily Change
0%
-
1 Month Change
0.8%
-
3 Month Change
2.3%
-
YoY Change
2.3%
Job Postings
Allogene Therapeutics currenly has an estimated 1 open job postings.
-
Job Postings
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
50%
-
YoY Change
50%
LinkedIn Employees
According to LinkedIn, Allogene Therapeutics has 223 employees, up by 0.9% over the last month.
-
LinkedIn Employees
223
-
Daily Change
0.9%
-
1 Month Change
0.9%
-
3 Month Change
11.2%
-
YoY Change
11.2%
Reddit Mentions
Allogene Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Allogene Therapeutics is 75 out of 100 (bullish).
-
Business Outlook
75
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
Allogene Therapeutics was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
ALLO Financials
ALLO Key Metrics
-
Total Revenue
$0
-
Net Income
-$59.9M
-
Earnings per Share
-$0.28
-
Free cash flow
-$37M
-
EBITDA
-$56.2M
-
EBITDA Ratio
0
-
Total Assets
$548.7M
ALLO 2-year Revenue & Income
ALLO 2-year Free Cash Flow
ALLO Technicals
ALLO SMA
ALLO RSI
FAQ
What's the current price of Allogene Therapeutics (ALLO) Stock?
The price of an Allogene Therapeutics (ALLO) share is $1.13.
What's the market cap of Allogene Therapeutics?
The current market cap of Allogene Therapeutics is 250.7M.
What are some stocks similar to Allogene Therapeutics (ALLO) that investors often compare it to?
Allogene Therapeutics (ALLO) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Allogene Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Allogene Therapeutics' stock price to be around $1.09 in 2026. Starting from the current price of $1.13, this represents a 3.9% change in price, indicating a neutral outlook for the stock.
How to buy Allogene Therapeutics (ALLO) Stock?
Allogene Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Allogene Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.